06:50 – 08:00 Registration
08:00 – 08:15 Welcome Remarks
Session 1: Inflammatory Arthritis
08:15 – 09:05 Aspects of Early, Established and Difficult to Treat Rheumatoid Arthritis Johannes W.J. Bijlsma
09:05 – 09:55 Cardiovascular Manifestations in the Rheumatic Diseases: What Rheumatologists Should Know? Sekib Sokolovic
09:55 – 10:25 Discover New Era in PsA Management
Industry Symposium by Janssen
Ghita Harifi
10:25 -10:45 Networking and Refreshment Break
Session 2: Osteoporosis & Metabolic Bone Diseases
10:45 – 11:35 Prevention and Treatment of Osteoporosis: 2021 Updates Nancy Lane
11:35 – 12:25 A New Paradigm in Management of Metabolic Bone Diseases Richard Keen
12:25 – 13:35 Prayer and Lunch Break
Session 3: Advances in Treatment of Rheumatic and Musculoskeletal Diseases
13:35 – 14:25 Spondyloarthritis Management: State of the Art 2021 Johannes W.J. Bijlsma
14:25 – 15:15 New FDA Approved Drug as a Treatment for SLE: What Should We Know? Andrea Doria
15:15 – 15:45 Are All JAKs the Same? JAKs Risk Benefit Assessment: An Experience From the Clinic                Industry Symposium by AbbVie Rajaie Namas
15:45 – 16:15 Importance of T2T: Remission and Patients QoL
in Golimumab RWE                             Industry Symposium by Janssen
Suad Hannawi
16:15 – 16: 35 Networking and Refreshment Break
Parallel Workshops
16:35 – 17:35 Workshop 1: X Linked Hypophosphatemia: Basic Guidance for Rheumatologists Nancy Lane
Workshop 2: The Intraarticular Applications of the Therapeutic Modalities in the Large and Small Joints Sekib Sokolovic
Workshop 3: Drug Holidays in Osteoporosis Richard Keen
Workshop 4: SLE and Pregnancy Hanan Al Rayes
End of Day 2
Download the Program
Register Now